Media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

MIDLAND, Texas — A recent outbreak of various respiratory diseases has been spreading throughout West Texas. This includes COVID-19, influenza AKA the flu, and respiratory syncytial virus, or RSV.

The North Carolina Department of Health and Human Services on Wednesday updated its weekly Respiratory Virus Summary Dashboard, which shows an increase in flu activity and flu-related deaths, bringing ...

There have been 117 flu-related deaths in North Carolina this season. According to NCDHHS, 51 new flu deaths were added to ...

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

DeWitt County is seeing an increase in stomach flu cases, primarily flu type A, along with rising COVID-19 cases, while ...

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...